Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration

Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence

NCT02070575 ·Status: COMPLETED

Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)

NCT02230059 ·Status: COMPLETED

Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC

NCT04506567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T

NCT05521412 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

NCT05352178 ·Status: RECRUITING ·Phase: PHASE3

Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic

NCT03101046 ·Status: COMPLETED ·Phase: PHASE2

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

NCT06070272 ·Status: NOT_YET_RECRUITING

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

NCT03315871 ·Status: COMPLETED ·Phase: PHASE2

Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy

NCT02452307 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Surgery in Treating Patients With Prostate Cancer

NCT00002938 ·Status: COMPLETED ·Phase: PHASE2

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

NCT05502315 ·Status: RECRUITING ·Phase: PHASE2

Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT

NCT05983198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

NCT05800665 ·Status: RECRUITING ·Phase: PHASE1

A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

NCT06009549 ·Status: NOT_YET_RECRUITING

Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer

NCT01558492 ·Status: TERMINATED ·Phase: PHASE2

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT07225946 ·Status: RECRUITING ·Phase: PHASE3

Long-Term Follow-Up in Patients With Prostate Cancer After Surgery

NCT03035500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer

NCT07156045 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

NCT05806515 ·Status: RECRUITING ·Phase: PHASE2

Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer

NCT02907372 ·Status: COMPLETED ·Phase: NA

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

NCT03471650 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

NCT06046131 ·Status: RECRUITING ·Phase: NA

Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients

NCT01254513 ·Status: COMPLETED ·Phase: PHASE2

An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors

NCT00514267 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer

NCT00916123 ·Status: COMPLETED ·Phase: PHASE1